YOPN insights

PRESS RELEASE - Young Onset Parkinson’s Network Announces New Sponsorship Agreement with Supernus Pharmaceuticals

08/15/2022 10:08 AM | Anonymous

Vienna, Va., August 5, 2022 – Young Onset Parkinson’s Network (YOPN) announced today a new sponsorship agreement with Supernus Pharmaceuticals. This sponsorship will provide financial support for key programming and resource opportunities for the young onset Parkinson’s population. YOPN is the only member-based organization exclusively focused on supporting the needs of the Young Onset Parkinson’s Disease (YOPD) community.

“We rely on the generosity of donors and sponsors to maintain a no-cost membership for our members,” notes YOPN Founder an Anna Grill. “With the support of Supernus, we will be able to continue to add new programs and resources that help our members live well and thrive.”

Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, including treatments for dyskinesia in Parkinson’s patients receiving levodopa-based therapy.

This initial sponsorship will help support YOPN’s speaker series, including an upcoming educational event on “Managing OFF Episodes in Parkinson’s Disease (PD)” with Dr. Mindy Bixby, Movement Disorder Specialist at Hoag Hospital in Laguna Beach, California. The sponsorship also will provide funding for the YOPN bi-monthly Podcast Series:  Living Well Starts HereSM  as well as upcoming membership discussions around the specific challenges facing those with YOPD.

About Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases.  Our diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, ADHD, hypomobility in PD, cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. We are developing a broad range of novel CNS product candidates including new potential treatments for hypomobility in PD, epilepsy, depression, and other CNS disorders. For more information, please visit www.supernus.com.

About Young Onset Parkinson’s Network (YOPN)

Young Onset Parkinson’s Network is a nonprofit, 501(c)(3) educational and charitable organization for those diagnosed with Young Onset Parkinson’s Disease (YOPD) as well as the individuals related to and/or caring for those with the disease. The organization seeks to increase awareness of YOPD by providing information, resources, and services to help members strengthen their mind and body within a supportive community. Through its network, YOPN members have the holistic support needed not only to manage, but to thrive with this unexpected, early diagnosis. To learn more, visit www.yopnetwork.org.

###

© 2021-2022 Young Onset Parkinson’s Network.
All rights reserved.

Young Onset Parkinson’s Network is sponsored in part by a grant from the Parkinson’s Foundation.


Powered by Wild Apricot Membership Software